CVS Health Valuation Overview

CVS -- USA Stock  

USD 74.50  2.62  3.65%

CVS Health shows prevailing Real Value of $88.941 per share. The current price of the firm is $74.5. At this time the firm appears to be under valued. Macroaxis approximates value of CVS Health from analyzing the firm fundamentals such as Return On Equity of 8.71% and Profit Margin of 1.65% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point future time assets prices and their ongoing real values will blend.
Investments

Valuation Drivers Correlation

Click cells to compare fundamentals   View All Correlations
CVS Health Corporation Valuation Data Drivers
Net Income Per Employee    Enterprise Value    Market Capitalization    

CVS Health Market Cap

CVS Health Corporation is rated second in market capitalization category among related companies. Market capitalization of Health Care Plans industry is currently estimated at about 450.86 Billion. CVS Health totals roughly 94.88 Billion in market capitalization claiming about 21% of equities under Health Care Plans industry.
Capitalization  Total debt  Valuation  Workforce  Revenue
Horizon     30 Days    Login   to change
CVS Health Corporation is rated second in five year return category among related companies. It is rated below average in price to book category among related companies fabricating about  1.07  of Price to Book per Five Year Return.

Current Market Valuation

CVS Health Valuation Boundaries

Under Valued
December 15, 2018
74.50
Market Value
88.94
Real Value
Target Odds
  
94.58
Upside
CVS Health is not too risky asset. Calculation of real value of CVS Health is based on 2 months time horizon. Increasing CVS Health time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.

Valuation Basics

CVS Health Enterprise Value Fundamentals

Quick Ratio1.92
Earnings Quarterly Growth8.20%
Revenue Growth2.40%
Payout Ratio66.01%
Enterprise Value To Ebitda7.65
Earnings Growth7.90%
Enterprise Value To Revenue0.51
Check also Trending Equities. Please also try Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Search macroaxis.com